Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109749801000001110 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109749901000001116 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Is a | Product containing papaveretum and scopolamine hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Has active ingredient | Scopolamine hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Has active ingredient | Papaveretum | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Has dispensed dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Has specific active ingredient | Scopolamine hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Has specific active ingredient | Papaveretum | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR